238 related articles for article (PubMed ID: 29048612)
1. Regulation of ERK and AKT pathways by hepatitis B virus X protein via the Notch1 pathway in hepatocellular carcinoma.
Liao B; Zhou H; Liang H; Li C
Int J Oncol; 2017 Nov; 51(5):1449-1459. PubMed ID: 29048612
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus X protein activates Notch signaling by its effects on Notch1 and Notch4 in human hepatocellular carcinoma.
Gao J; Xiong Y; Wang Y; Wang Y; Zheng G; Xu H
Int J Oncol; 2016 Jan; 48(1):329-37. PubMed ID: 26530164
[TBL] [Abstract][Full Text] [Related]
3. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
Yu G; Chen X; Chen S; Ye W; Hou K; Liang M
J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus X protein promotes interleukin-7 receptor expression via NF-κB and Notch1 pathway to facilitate proliferation and migration of hepatitis B virus-related hepatoma cells.
Kong F; Hu W; Zhou K; Wei X; Kou Y; You H; Zheng K; Tang R
J Exp Clin Cancer Res; 2016 Nov; 35(1):172. PubMed ID: 27821177
[TBL] [Abstract][Full Text] [Related]
5. Notch1 is a potential therapeutic target for the treatment of human hepatitis B virus X protein-associated hepatocellular carcinoma.
Sun Q; Wang R; Wang Y; Luo J; Wang P; Cheng B
Oncol Rep; 2014 Feb; 31(2):933-9. PubMed ID: 24336972
[TBL] [Abstract][Full Text] [Related]
6. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B Virus HBx Activates Notch Signaling via Delta-Like 4/Notch1 in Hepatocellular Carcinoma.
Kongkavitoon P; Tangkijvanich P; Hirankarn N; Palaga T
PLoS One; 2016; 11(1):e0146696. PubMed ID: 26766040
[TBL] [Abstract][Full Text] [Related]
8. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Deng X; Zhao XF; Liang XQ; Chen R; Pan YF; Liang J
Biomed Pharmacother; 2017 Jun; 90():100-108. PubMed ID: 28343069
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus X protein promotes human hepatoma cell growth via upregulation of transcription factor AP2α and sphingosine kinase 1.
Lu ZP; Xiao ZL; Yang Z; Li J; Feng GX; Chen FQ; Li YH; Feng JY; Gao YE; Ye LH; Zhang XD
Acta Pharmacol Sin; 2015 Oct; 36(10):1228-36. PubMed ID: 26073327
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus X protein increases microRNA‑21 expression and accelerates the development of hepatoma via the phosphatase and tensin homolog/phosphoinositide 3‑kinase/protein kinase B signaling pathway.
Hou Z; Quan J
Mol Med Rep; 2017 May; 15(5):3285-3291. PubMed ID: 28339072
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus induces hypoxia-inducible factor-2α expression through hepatitis B virus X protein.
Hu JL; Liu LP; Yang SL; Fang X; Wen L; Ren QG; Yu C
Oncol Rep; 2016 Mar; 35(3):1443-8. PubMed ID: 26647960
[TBL] [Abstract][Full Text] [Related]
12. Interaction of lncRNA-MALAT1 and miR-124 regulates HBx-induced cancer stem cell properties in HepG2 through PI3K/Akt signaling.
He B; Peng F; Li W; Jiang Y
J Cell Biochem; 2019 Mar; 120(3):2908-2918. PubMed ID: 30500989
[TBL] [Abstract][Full Text] [Related]
13. HBx-induced miR-21 suppresses cell apoptosis in hepatocellular carcinoma by targeting interleukin-12.
Yin D; Wang Y; Sai W; Zhang L; Miao Y; Cao L; Zhai X; Feng X; Yang L
Oncol Rep; 2016 Oct; 36(4):2305-12. PubMed ID: 27571873
[TBL] [Abstract][Full Text] [Related]
14. A novel mutant 10Ala/Arg together with mutant 144Ser/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell lines.
Shi Y; Wang J; Wang Y; Wang A; Guo H; Wei F; Mehta SR; Espitia S; Smith DM; Liu L; Zhang Y; Chen D
Cancer Lett; 2016 Feb; 371(2):285-91. PubMed ID: 26706415
[TBL] [Abstract][Full Text] [Related]
15. c-Jun N-terminal kinase inhibitor favors transforming growth factor-β to antagonize hepatitis B virus X protein-induced cell growth promotion in hepatocellular carcinoma.
Wu YH; Ai X; Liu FY; Liang HF; Zhang BX; Chen XP
Mol Med Rep; 2016 Feb; 13(2):1345-52. PubMed ID: 26648552
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus X protein and hypoxia‑inducible factor-1α stimulate Notch gene expression in liver cancer cells.
Yang SL; Ren QG; Zhang T; Pan X; Wen L; Hu JL; Yu C; He QJ
Oncol Rep; 2017 Jan; 37(1):348-356. PubMed ID: 27840976
[TBL] [Abstract][Full Text] [Related]
17. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic knockdown of Notch1 inhibits hepatitis B virus X protein‑induced hepatocarcinogenesis of L02/HBx cells.
Peng Y; Zhou D; Ye Y; Kai C; Jiang Z; Zhu Z; Wu X; Xiong J
Oncol Rep; 2019 Feb; 41(2):1151-1159. PubMed ID: 30431136
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus X protein blunts senescence-like growth arrest of human hepatocellular carcinoma by reducing Notch1 cleavage.
Xu J; Yun X; Jiang J; Wei Y; Wu Y; Zhang W; Liu Y; Wang W; Wen Y; Gu J
Hepatology; 2010 Jul; 52(1):142-54. PubMed ID: 20578140
[TBL] [Abstract][Full Text] [Related]
20. HBX suppresses PTEN to promote the malignant progression of hepatocellular carcinoma through mi-R155 activation.
Niu LJ; Huang T; Wang L; Sun XF; Zhang YM
Ann Hepatol; 2022; 27(3):100688. PubMed ID: 35196550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]